Novel Stratification of Mortality Risk by Kidney Disease Stage

Conclusion: IMRS is a strong predictor of mortality in patients with CKD and is robustly complementary to CKD stage in refining risk prediction. Given the universal availability and low cost of the CBC and BMP, IMRS may be of a substantial value in CKD risk assessment and management.Am J Nephrol 2015;42:443-450
Source: American Journal of Nephrology - Category: Neurology Source Type: research